Francesca Carlomagno

Receptor tyrosine kinase inhibitors in thyroid cancer.

Giuliana Salvatore, M. Santoro, M. Castellone, 2008, Best practice & research. Clinical endocrinology & metabolism.

Functional characterization of a novel FGFR1OP‐RET rearrangement in hematopoietic malignancies

Giancarlo Pruneri, Isabella Pallavicini, Daniela Bossi, 2014, Molecular oncology.

The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells.

Giancarlo Troncone, Gennaro Chiappetta, G. Chiappetta, 2010, Endocrine-related cancer.

The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes.

Teresa Guida, Alexander Levitzki, M. Santoro, 2002, Cancer research.